Pharmaceutical companies in talks with NICE about access to Alzheimer’s drugs Drug manufacturers Lilly and Eisai are in discussion with the National Institute for Health and Care Excellence to appeal the regulator’s rejection of the use of donanemab and lecanemab on the NHS for the third time in June 2025.…
Negotiator to challenge prime minister on business rates relief Community Pharmacy England said it had made a “clear case” for business rates relief during funding negotiations and will put these arguments to Andy Burnham's government.…
Everything you need to know about clinical trial legislation changes Clinical trial legislation has been overhauled to speed up set-up times and include a broader range of healthcare professionals, but what do the reforms mean for patients and pharmacists?…
Yvette Cooper named health secretary Newly appointed secretary of state for health and social care, Yvette Cooper, moves from her previous role as foreign secretary.…
Coroner raises concerns over lack of national guidance on prescribing for hepatitis B reactivation A patient died from complications from reactivation of hepatitis B, after the supply of viral reactivation prophylaxis was inadvertently discontinued.…
Pharmacists having to procure their own pandemic PPE ‘a major failure in planning’, finds COVID-19 inquiry The COVID 19 inquiry report described the government's personal protective equipment distribution plans as “inadequate”.…
Single national formulary pilot sites announced NHS England said that 13 early adopter integrated care boards will transition to the single national formulary by December 2026.…
Short-term savings, long-term costs: what cuts to medicines optimisation teams could mean for the NHS Integrated care boards have confirmed to The Pharmaceutical Journal that they are reducing headcount in their medicines optimisation teams, which are primarily formed of pharmacists. What will this mean for the future NHS?…
Government ‘missing huge trick’ excluding pharmacies from NHS capital investment plan, say leaders Pharmacy organisation leaders have said the exclusion of pharmacy from the NHS capital investment plan could hinder the expansion of services where patients need them.…
Community pharmacy could help ease £2.7bn delayed discharge bill King’s Fund analysis of NHS England data has suggested that hospital beds being taken up by someone fit enough to be discharged are costing the NHS £562 per day.…
